Randomized phase II trial of the carboxylesterase (CES)-converted novel drug EDO-S7.1 in patients (pts) with advanced biliary tract cancers (BTC).

CAP 7.1 - Mundipharma

https://meetinglibrary.asco.org/record/168798

Ulrich-Frank Pape; Stefan Kasper; Johannes Meiler; Marianne Sinn; Arndt Vogel; Lothar Mueller; Oswald Burkhard; Karel Caca; Steffen Heeg; Victor Rodriguez Laval; Anya A Kühl; Ruza Arsenic; Holger Jansen; Nalan Utku

Jan 15, 2019